San Francisco, CA 2019

Managing the Ocular Surface to Improve Surgical Outcomes: Protocols, Diagnostics, and Definitive Treatment Decisions

Supported By: Allergan Inc., Johnson & Johnson Vision, Sun Pharmaceutical Industries, Inc., and Takeda

 

San Francisco

Saturday, October 12, 2019

 

 


City/State/Country: San Francisco, CA USA
Venue: Palace Hotel
Room Location: Concert Ballroom, First Floor
Registration: 6:30 AM - 7:00 AM
Program: 7:00 AM - 8:00 AM

Moderators:

  • Eric D. Donnenfeld, MD
  • Elizabeth Yeu, MD

 

Faculty:

  • Marjan Farid, MD
  • Francis Mah, MD
  • Christopher E. Starr, MD

Preliminary Program

OSD:

 

7:00 Welcome and Introduction — Eric D. Donnenfeld, MD and Elizabeth Yeu, MD

 

7:10 Protocols to Assess Ocular Surface Disease in Preoperative Patients — Christopher E. Starr, MD

 

7:20 What We’ve Learned: How to Improve Surgical Outcomes — Marjan Farid, MD

 

7:30 Real-world Management of the Ocular Surface: What I Do in My Clinical Practice — Francis Mah, MD

 

7:40 Putting it All Together: From Algorithm to Treatment and Surgical Outcomes — All Faculty

 

8:00 Conclude